2-(2-Chloroacetamido)acetic acid

Catalog No.: 
ACQXCO195
CAS No.: 
6319-96-6
Molecular Formula: 
C4H6ClNO3
Molecular Weight: 
151.55
2-(2-Chloroacetamido)acetic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$64.00In stockIn stock
25g98%$211.00In stockIn stock
100g98%$827.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(2-Chloroacetamido)acetic acid
IUPAC Name(2-chloroacetyl)glycine
MDL No.MFCD00021733
Molecular FormulaC4H6ClNO3
Molecular Weight151.55
SMILESO=C(CNC(CCl)=O)O
InChI KeyDLDTUYIGYMNERN-UHFFFAOYSA-N
SynonymSTK967059 | SCHEMBL1965772 | FD21633 | CS-0201686 | AS-49140 | HY-W141892 | 2-(2-chloroacetamido)acetic acid | Glycine, N-(chloroacetyl)- | FT-0629115 | Chloroacetyl glycine | n-(chloroacetyl)glycine | 2-[(2-chloroacetyl)amino]acetic acid | MFCD00021733 |
CAS No.6319-96-6
PubChem CID233485

Synthetic Route by SureRoute

1. ACQXCO195 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEUXN150 route compound structure diagram
    ACEUXN150475473-26-8In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQXCO195 route product structure diagram
    ACQXCO1956319-96-6In Stock
Inquiry

2. ACQXCO195 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACEUXN150 route compound structure diagram
    ACEUXN150475473-26-8In Stock
  4. Then
  5. ACQXCO195 route product structure diagram
    ACQXCO1956319-96-6In Stock
Inquiry

3. ACQXCO195 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACEUXN150 route compound structure diagram
    ACEUXN150475473-26-8In Stock
  4. Then
  5. ACQXCO195 route product structure diagram
    ACQXCO1956319-96-6In Stock
Inquiry

Comments (0)